HOME › DRUGS › INSULIN GLULISINE RECOMBINANT
ACTIVE SUBSTANCE / INN

INSULIN GLULISINE RECOMBINANT

Brand name(s): APIDRA SOLOSTAR, APIDRA
FDA LISTED
PRESCRIPTION
DISCONTINUED
BLA021629
ACTIVE SUBSTANCE
Insulin Glulisine Recombinant
REGULATORS
FDA
SPONSORS / MAH
SANOFI AVENTIS US
TOTAL APPLICATIONS
3
FDA APPLICATIONS (DRUGS@FDA)
BRAND NAMEAPPLICATIONSPONSORSTATUS
APIDRA SOLOSTARBLA021629SANOFI AVENTIS USPrescription
APIDRABLA021629SANOFI AVENTIS USPrescription
APIDRABLA021629SANOFI AVENTIS USDiscontinued

FULL INTELLIGENCE ON INSULIN GLULISINE RECOMBINANT

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →